The U.S. military relies on a network of countries around the world to produce the sophisticated weapons and equipment that ...

AbbVie raised its full-year profit forecast on Friday while downplaying the potential hit some analysts expect it to take ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

First Solar is a strategic investment, benefiting from onshore manufacturing, strong financials & renewable energy demand.

A revival of the defense sector can only take place if Congress and the DOD reform the incentive structures governing defense production.

Nigeria’s manufacturing investments plunged 35 percent in 2024, as high interest rate crush appetite for capita-intensive ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

In an email, the spokesperson said the selected Mentor for its first U.S. plant "due to its strategic proximity to key ...

AbbVie Inc. reports a strong Q1 2025 with EPS of $2.46 and raised guidance, fueled by Skyrizi, Rinvoq, and neuroscience growth.

The economy today is truly global. Tariffs would be great if the U.S. were the only source of certain goods, but we’re not.

The back-and-forth nature has caused a more uncertain business climate compared to tariff talks of the first Trump ...

The sub-indicator for subcontractor labor costs jumped to 82.4 in April from 68.5 in March. Engineering and construction ...